Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant. Nahshon C, Fahoum L, Hadar D, Cohen H, et al. Breast Cancer 2026;33:1271-1279.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nahshon C, Fahoum L, Hadar D, Cohen H, et al. Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant. Breast Cancer 2026;33:1271-1279.
PMID: 42611417